Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Sanofi and Regeneron's medical congress campaign focuses on type 2 inflammation education for docs
Fierce Pharma
Tue, 11/19/19 - 11:36 pm
Tags:
Sanofi Genzyme, Regeneron, Dupixent, inflammation
Regeneron Pharmaceuticals Earnings: REGN Stock Rockets 7% on Q3 Beat
Investor Place
Tue, 11/5/19 - 11:57 pm
Tags:
Regeneron, earnings
Regeneron defends bid to challenge Merck in lung cancer
Biopharma Dive
Tue, 11/5/19 - 11:45 pm
Tags:
Regeneron, Libtayo, Merck, Keytruda, immuno-oncology, lung cancer
Regeneron profit beats expectations on Eylea, Dupixent strength
Yahoo/Reuters
Tue, 11/5/19 - 10:15 am
Tags:
Regeneron, earnings, Eylea, Dupixent
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Yahoo/Zacks.com
Mon, 11/4/19 - 07:33 pm
Tags:
Allergan, Regeneron, Mylan, Catalent, Jazz Pharmaceuticals
Eylea could be in trouble, but that doesn't make Regeneron a buyer
Biopharma Dive
Fri, 10/25/19 - 12:09 pm
Tags:
Regeneron, M&A, Eylea
Glenmark spin-out aims to challenge Amgen, others in cancer bispecific field
Biopharma Dive
Tue, 10/15/19 - 10:21 pm
Tags:
Glenmark, Ichnos Sciences, India, Amgen, oncology, Regeneron, bispecific antibodies
Pfizer posts detailed phase 3 data on its Dupixent rival
Fierce Biotech
Sat, 10/12/19 - 12:30 pm
Tags:
Pfizer, clinical trials, atopic dermatitis, abrocitinib, Dupixent, Sanofi, Regeneron
Eylea casts a shadow over Novartis' latest approval
Biopharma Dive
Wed, 10/9/19 - 11:04 pm
Tags:
Novartis, Beovu, wet age-related macular degeneration, Regeneron, Eylea
Novartis backs brolucizumab with new head-to-head Eylea trial
Pharmaforum
Mon, 09/9/19 - 08:15 pm
Tags:
Novartis, clinical trials, brolucizumab, Eylea, Bayer, Regeneron, age-related macular degeneration
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Wed, 08/28/19 - 10:52 pm
Tags:
Sanofi, Regeneron, Amgen, PCSK9 inhibitors, patents, Praluent, Repatha
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Fierce Pharma
Tue, 08/27/19 - 12:04 pm
Tags:
Amgen, Regeneron, Sanofi, Praluent, Repatha, Medicines Company, PCSK9 inhibitors, inclisiran
Mon, 08/19/19 - 10:20 am
Tags:
Regeneron, Novartis, wet-AMD, Eylea, ethics, Vertex Pharmaceuticals, Kalydeco, cystic fibrosis, Bristol-Myers Squibb, Opdivo, Merck, Keytruda, SCLC
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Sun, 08/18/19 - 04:30 pm
Tags:
Regeneron, Novartis, wet-AMD, Eylea, ethics, Vertex Pharmaceuticals, Kalydeco, cystic fibrosis, Bristol-Myers Squibb, Opdivo, Merck, Keytruda, SCLC
Regeneron plots $800M New York production push—along with 1,500 new jobs
Fierce Pharma
Wed, 08/14/19 - 07:09 pm
Tags:
Regeneron, drug manufacturing, New York
Regeneron drug proves effective in genetic form of high cholesterol
Stat
Wed, 08/14/19 - 10:14 am
Tags:
Regeneron, Homozygous Familial Hypercholesterolemia, evinacumab
Regeneron gets FDA approval for Eylea injection prefilled syringe
Ophthalmology Times
Tue, 08/13/19 - 10:34 am
Tags:
Regeneron, Eylea, FDA
Regeneron's Ebola treatment proves superior to rival in trial
Yahoo/Reuters
Mon, 08/12/19 - 10:33 am
Tags:
Regeneron, Ebola, Mapp Biopharmaceutical, REGN-EB3
Dupixent brings long-awaited profits to Sanofi, Regeneron partnership
BioPharma Dive
Tue, 08/6/19 - 01:09 pm
Tags:
Sanofi, Regeneron, Dupixent
These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger
Investors Business Daily
Fri, 07/19/19 - 10:44 am
Tags:
Bristol-Myers Squibb, Celgene, M&A, Otezla, Gilead Sciences, Amgen, Regeneron, Eli Lilly, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.